Thyrocare Technologies Limited
Symbol: THYROCARE.BO
BSE
603.8
INRTrhová cena dnes
50.3318
Pomer P/E
0.9063
Pomer PEG
31.97B
MRK Cap
- 0.00%
Výnos DIV
Thyrocare Technologies Limited (THYROCARE-BO) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1400.7 | 1388.4 | 1176.9 | |||||||||
balance-sheet.row.short-term-investments | 0 | 1223 | 1252.1 | 1044.9 | |||||||||
balance-sheet.row.net-receivables | 0 | 856.7 | 944.8 | 513.5 | |||||||||
balance-sheet.row.inventory | 0 | 276.7 | 245.3 | 233.6 | |||||||||
balance-sheet.row.other-current-assets | 0 | 53.2 | 112.8 | 28.4 | |||||||||
balance-sheet.row.total-current-assets | 0 | 2729.4 | 2700.2 | 2404.4 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1944.3 | 1867.9 | 1600.9 | |||||||||
balance-sheet.row.goodwill | 0 | 1002.8 | 1002.8 | 1002.8 | |||||||||
balance-sheet.row.intangible-assets | 0 | 7.9 | 8.3 | 9.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1010.7 | 1011.1 | 1012.5 | |||||||||
balance-sheet.row.long-term-investments | 0 | 223.1 | 243.8 | 270.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 122.7 | 64.9 | 56.3 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 297 | 188.7 | 113.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 3597.8 | 3376.4 | 3053.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.account-payables | 0 | 239.9 | 165.3 | 250.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 71.9 | 50 | 30.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 18.3 | 18.3 | 18.6 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 161.2 | 157 | 54.5 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 91.9 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 398.4 | 336.5 | 312.5 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 204 | 165.7 | 234.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.total-liab | 0 | 975 | 810.9 | 1185.2 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 529.3 | 529 | 528.7 | |||||||||
balance-sheet.row.retained-earnings | 0 | 3434.2 | 3568.8 | 2599.2 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1255.9 | 1244.1 | 1225.8 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 123.6 | -76.2 | -80.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5343 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.minority-interest | 0 | 9.2 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 5352.2 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 221 | 209.2 | 211 | |||||||||
balance-sheet.row.total-debt | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.net-debt | 0 | 55.4 | 70.7 | -47.1 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 874.1 | 2279 | 1525.4 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -247.4 | -731.2 | -522.2 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 211.7 | 23.2 | 16.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 57.9 | -792.2 | -176.5 | |||||||||||
cash-flows.row.account-receivables | 0 | -14.3 | -587.2 | -288.1 | |||||||||||
cash-flows.row.inventory | 0 | -31.4 | -11.7 | -27.4 | |||||||||||
cash-flows.row.account-payables | 0 | 74.2 | -84.8 | 31.5 | |||||||||||
cash-flows.row.other-working-capital | 0 | 29.4 | -108.5 | 107.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 9.7 | 16.6 | 1 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 30.2 | 42.5 | 42.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -1919.9 | -1730 | -1361.1 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1932.5 | 1593.5 | 1042.1 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 3.8 | 236.6 | 56.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -389.9 | -235.7 | -486.6 | |||||||||||
cash-flows.row.debt-repayment | 0 | -55.3 | -53.8 | -25 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.3 | 0.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | -55.3 | -53.8 | -62.6 | |||||||||||
cash-flows.row.dividends-paid | 0 | -793.5 | -793.1 | -528.4 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 42 | 6.3 | -0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -861.8 | -894.1 | -615.8 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -2.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 41.4 | 4.3 | 44.9 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 177.7 | 136.3 | 132 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 136.3 | 132 | 87.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 1293.1 | 1134.1 | 1147.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 856.6 | 755.8 | 880.4 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 5266.7 | 5888.6 | 4946.2 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 1632.3 | 1696.9 | 1639 | |||||||||
income-statement-row.row.gross-profit | 0 | 3634.4 | 4191.7 | 3307.2 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.operating-expenses | 0 | 2788.2 | 2173.1 | 1895.9 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 4420.5 | 3870 | 3534.9 | |||||||||
income-statement-row.row.interest-income | 0 | 13.8 | 7.1 | 7.9 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 865.5 | 2044.2 | 1455.9 | |||||||||
income-statement-row.row.income-before-tax | 0 | 885.9 | 2277.2 | 1524.7 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 242.3 | 515.8 | 393.2 | |||||||||
income-statement-row.row.net-income | 0 | 643.6 | 1761.4 | 1131.5 |
Často kladené otázky
Čo je Thyrocare Technologies Limited (THYROCARE.BO) celkové aktíva?
Thyrocare Technologies Limited (THYROCARE.BO) celkové aktíva sú 6327200000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.708.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 16.845.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.118.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.151.
Aká je Thyrocare Technologies Limited (THYROCARE.BO) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 643600000.000.
Aký je celkový dlh firmy?
Celkový dlh je 233100000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 2788200000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.